Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.

Pharmacogenomics - 1 Aug 2001

Kerb R, Brinkmann U

Abstract excerpt

Pharmacogenomics promises to offer distinct strategic advantages to pharmaceutical companies, physicians, providers and patients. Cambridge Healthtech Institute's 2nd Annual Conference on 'Pharmacogenomics Europe: Presaging Profits' covered all aspects of pharmacogenomics and gave scientists from both academia and from pharmaceutical and biotech companies a great opportunity to discuss the latest progress in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Profiling
Share to Oligonucleotide Array Sequence Analysis
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 11939136
DOI: 10.1517/14622416.2.3.303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.PMID 11939136Read ↗

Emerging strategies and applications of pharmacogenomics.Semantic proximity Read ↗

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs.Semantic proximity Read ↗

Welcome to the 19th volume of Pharmacogenomics.Semantic proximity Read ↗

Developments in pharmacogenetics, pharmacogenomics, and personalized medicineSemantic proximity Read ↗

Perlegen sciences, inc.Semantic proximity Read ↗

[Pharmacogenomics: hype or hope?].Semantic proximity Read ↗

The Pennsylvania State University College of Medicine 1990 Bernard B. Brodie Lecture. Pharmacogenetics: past and future.Semantic proximity Read ↗

Essential Characteristics of Pharmacogenomics Study PublicationsSemantic proximity Read ↗

Pharmacogenomics in drug development: societal and technical aspects.Semantic proximity Read ↗

[A new approach to pharmacogenomics].Semantic proximity Read ↗

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.Semantic proximity Read ↗

Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.